These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Arthritis treatment in Hong Kong--cost analysis of celecoxib versus conventional NSAIDS, with or without gastroprotective agents. You JH, Lee KK, Chan TY, Lau WH, Chan FK. Aliment Pharmacol Ther; 2002 Dec; 16(12):2089-96. PubMed ID: 12452942 [Abstract] [Full Text] [Related]
15. Raising the safety bar--the FDA's coxib meeting. Okie S. N Engl J Med; 2005 Mar 31; 352(13):1283-5. PubMed ID: 15800221 [No Abstract] [Full Text] [Related]
16. [Selective Cox-2 inhibitor in osteoarthritis and rheumatoid arthritis. No increased risk for the heart]. MMW Fortschr Med; 2003 Mar 13; 145(11):60. PubMed ID: 12688204 [No Abstract] [Full Text] [Related]
19. [Mobility and quality of life for arthrosis and rheumatism patients. Modern pain management with selective cox-2 inhibition]. MMW Fortschr Med; 2002 Jul 26; 144(29-30):52. PubMed ID: 12219613 [No Abstract] [Full Text] [Related]